These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25178216)

  • 1. [Re: Patients who terminate OMT--how do they fare?].
    Helgesen R
    Tidsskr Nor Laegeforen; 2014 Sep; 134(16):1548. PubMed ID: 25178216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Re: Patients who terminate OMT--how do they fare?].
    Kristensen Ø; Clausen T; Åsland R
    Tidsskr Nor Laegeforen; 2014 Sep; 134(16):1548-9. PubMed ID: 25178217
    [No Abstract]   [Full Text] [Related]  

  • 3. Patients who terminate OMT--how do they fare?
    Clausen T; Åsland R; Kristensen Ø
    Tidsskr Nor Laegeforen; 2014 Jun; 134(11):1146-50. PubMed ID: 24939781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study.
    Bukten A; Skurtveit S; Waal H; Clausen T
    Addict Behav; 2014 Oct; 39(10):1504-9. PubMed ID: 24960556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in Georgia opioid substitution therapy program and associated factors.
    Ruadze E; Todadze K
    Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada.
    Franklyn AM; Eibl JK; Gauthier GJ; Pellegrini D; Lightfoot NE; Marsh DC
    Int J Drug Policy; 2017 Oct; 48():1-8. PubMed ID: 28666202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid maintenance treatment: trajectories in and out of treatment.
    Monwell B; Gerdner A
    Nord J Psychiatry; 2019 Jan; 73(1):24-30. PubMed ID: 30636473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriptions Filled Following an Opioid-Related Hospitalization.
    Naeger S; Ali MM; Mutter R; Mark TL; Hughey L
    Psychiatr Serv; 2016 Nov; 67(11):1262-1264. PubMed ID: 27247179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who uses methadone services in China? Monitoring the world's largest methadone programme.
    Sullivan SG; Wu Z; Rou K; Pang L; Luo W; Wang C; Cao X; Yin W; Liu E; Mi G;
    Addiction; 2015 Jan; 110 Suppl 1():29-39. PubMed ID: 25533862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
    Muller AE; Bjørnestad R; Clausen T
    Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario.
    Franklyn AM; Eibl JK; Gauthier G; Pellegrini D; Lightfoot NE; Marsh DC
    Harm Reduct J; 2017 Jan; 14(1):6. PubMed ID: 28122579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Maintenance Treatment--A Call for a Joint European Quality Care Approach.
    Brandt L; Unger A; Moser L; Fischer G; Jagsch R
    Eur Addict Res; 2016; 22(1):36-51. PubMed ID: 26314296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
    Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
    Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
    Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
    Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of patient retention in methadone maintenance treatment.
    Proctor SL; Copeland AL; Kopak AM; Hoffmann NG; Herschman PL; Polukhina N
    Psychol Addict Behav; 2015 Dec; 29(4):906-17. PubMed ID: 26098127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
    Bukten A; Skurtveit S; Gossop M; Waal H; Stangeland P; Havnes I; Clausen T
    Addiction; 2012 Feb; 107(2):393-9. PubMed ID: 21883606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice].
    Dupouy J; Bez J; Barsony J; Oustric S; Lapeyre-Mestre M
    Therapie; 2013; 68(3):155-61. PubMed ID: 23886460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison.
    Mjåland K
    Int J Drug Policy; 2015 Aug; 26(8):781-9. PubMed ID: 26025481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Re: Opioid maintenance treatment--important treatment with dilemmas].
    Helgesen R
    Tidsskr Nor Laegeforen; 2014 Sep; 134(16):1547. PubMed ID: 25178214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.